Work Here?
Vitreous-Retina-Macula Consultants of New York PC
Work Here?
Specializes in vitreoretinal diagnosis and surgery
Vitreous-Retina-Macula Consultants of New York PC
Work Here?
Specializes in vitreoretinal diagnosis and surgery
Overview
VRMNY provides specialized retinal care in New York, diagnosing and treating retinal diseases such as macular degeneration and diabetic retinopathy, and performing vitreoretinal surgeries including vitrectomy. Patients receive medical management and surgical treatment across its Manhattan and Downtown centers, with care coordinated by a team of retina specialists. The group stands out through its physicians’ international recognition, academic appointments at Lenox Hill Hospital, NYU, and NY Eye and Ear Infirmary, and its status as the largest retina-vitreous center in the NYC area. The goal is to diagnose, treat, and manage retinal diseases to preserve and restore vision for patients across multiple locations.
About Vitreous-Retina-Macula Consultants of New York PC
Industries
Healthcare
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
1974
Get referred to Vitreous-Retina-Macula Consultants of New York PC
See people who can refer or advise you
Simplify's Take
What believers are saying
- Updated June 2026 research pages list ARCHER, 4D-150, HONU, and AO studies.
- Practice continues recruiting for MAKO and BOULEVARD trials, sustaining patient acquisition.
- Four New York offices and urgent retina care support steady regional demand and repeat referrals.
What critics are saying
- Regenxbio trial success threatens their injection-heavy revenue base by replacing chronic anti-VEGF visits.
- Ten-physician single-specialty model concentrates key-person risk around senior partners and fellows.
- Brooklyn and Westchester locations still depend on Manhattan referrals if payer mix weakens.
What makes Vitreous-Retina-Macula Consultants of New York PC unique
- Largest retina center in the New York Metropolitan area across four offices.
- Deep subspecialty bench: ten retinal physicians, including Spaide, Freund, Yannuzzi, and Cooney.
- Only Manhattan site in Regenxbio's wet AMD gene-therapy study, announced October 2023.
Help us improve and share your feedback! Did you find this helpful?
Benefits
401(k) Company Match
Dental Insurance
Flexible Spending Account
Health Insurance
Life Insurance
Parental Leave
Health Savings Account
Vision Insurance
Company News
NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that its esteemed ophthalmologist Richard F. Spaide, MD, was awarded the Arnall Patz Medal at The Macula Society 's 47th Annual Meeting on February 9th, 2024.Dr. Spaide was selected as the honoree of the Arnall Patz Medal by the awards committee of The Macula Society. The Macula Society is the preeminent organization for specialists in the field of macula and retinal diseases. The Arnall Patz Medal is awarded to those who have made outstanding contributions to the understanding of retinal vascular diseases in honor of ophthalmologist Arnall Patz, who is known for his landmark work on retinopathy of prematurity.Dr
NEW YORK, Jan. 5, 2024 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that its esteemed ophthalmologist K. Bailey Freund, MD will serve as the Program Director of the 48th Annual Atlantic Coast Retina Club (ACRC) & 24th Macula Conference (Macula 2024).The ACRC was originally co-founded by Lawrence Yannuzzi, MD, co-founder of VRMNY, as a one-day Friday conference open to all retinal specialists. Twenty-three years after the first ACRC meeting, Dr. Yannuzzi created a Saturday program and Macula 2000 was born.The Conference will take place from January 4th through the 6th at the New York Academy of Medicine, 1216 5th Avenue in New York City.Expected to attract between 400-500 retina specialists from around the world, the meetings' participants will learn about new therapies, recent clinical trial results, artificial intelligence, and the latest retinal imaging technologies. The goal of the conference is to help clinicians better manage their patients with macular and retinal disorders and achieve better patient outcomes in their practices."Our meeting this year promises to provide new insight into current critical issues which are inherent in retinal diseases and their treatments," said K
Currently Enrolling Patients Suffering from Wet Age-Related Macular DegenerationNEW YORK, Oct. 17, 2023 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that they have been selected to participate in an innovative Wet AMD study in collaboration with Regenxbio. Wet age-related macular degeneration (wet AMD) is a severe visual impairment caused by the development of new leaky blood vessels in the retina, an essential tissue responsible for vision.VRMNY will be the only Manhattan-based site to participate in the study, which will offer an investigational therapy to patients. The therapy is designed to deliver a targeted gene directly to the retina, in order for these cells to produce an anti-VEGF protein. This groundbreaking approach has the potential to reduce, or even eliminate, the frequent need for anti-VEGF injections, which are the current standard of care for wet AMD.Dr. Richard F
Vitreous-Retina-Macula Consultants of New York PC is Hiring for 5 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Vitreous-Retina-Macula Consultants of New York PC
Industries
Healthcare
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
1974
Vitreous-Retina-Macula Consultants of New York PC is Hiring for 5 Jobs on Simplify!
Find jobs on Simplify and start your career today